Dennis L. Bergquist

CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL.

ReEnergy Group Plc provides waste management and water desalination technology. The waste management business processes municipal waste using Fibrecycle technology to recover recyclable materials and produce re-usable organic fibre. The waste management business also produces high grade combustible fuel from solid waste which is used as a substitute for coal at power plants and cement kilns. The company was founded on November 9, 2004 and is headquartered in London, the United Kingdom.